Article
Augmentation of antitumor immunity by fusions of ethanol-treated tumor cells and dendritic cells stimulated via dual TLRs through TGF-β1 blockade and IL-12p70 production.
PloS one - 1 Jan 2013
Koido Shigeo, Homma Sadamu, Okamoto Masato, Namiki Yoshihisa, Takakura Kazuki, Takahara Akitaka, Odahara Shunichi, Tsukinaga Shintaro, Yukawa Toyokazu, Mitobe Jimi, Matsudaira Hiroshi, Nagatsuma Keisuke, Kajihara Mikio, Uchiyama Kan, Arihiro Seiji, Imazu Hiroo, Arakawa Hiroshi, Kan Shin, Hayashi Kazumi, Komita Hideo, Kamata Yuko, Ito Masaki, Hara Eiichi, Ohkusa Toshifumi, Gong Jianlin, Tajiri Hisao
Abstract excerpt
The therapeutic efficacy of fusion cell (FC)-based cancer vaccine generated with whole tumor cells and dendritic cells (DCs) requires the improved immunogenicity of both cells. Treatment of whole tumor cells with ethanol resulted in blockade of immune-suppressive soluble factors such as transforming growth factor (TGF)-β1, vascular endothelial growth factor, and IL-10 without decreased expression of major...
Topics
- Cell Fusion
- Cell Line, Tumor
- Cytokines
- Dendritic Cells
- Ethanol
- Humans
- Immunologic Factors
- Immunotherapy, Adoptive
